Voluntary announcement on-market share repurchase under general mandate
Filed with HKEX · Stock code 7666 · · 2 pages · English
Summary by 6ix AI
The repurchase will be funded through the company's own resources and is intended to reflect confidence in its business outlook. The company has not yet repurchased any shares under this mandate, and the execution of the plan will depend on market conditions. Shareholders are advised to exercise caution as there is no guarantee regarding the timing or amount of shares that will be repurchased.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Metis TechBio Co., Ltd. on 6ix
Earlier from Metis TechBio
- Inside information proposed a share listing plan
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
- Voluntary announcement Metis TechBio entered strategic collaboration with lilly to advance next-generation tissue-specific LNP delivery technologies
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- 2026 Interim Report
Follow Metis TechBio into a list and get an email when it puts out news.
Follow Metis TechBio